Andrew Summers Sells 17,463 Shares of Electromed, Inc. Stock
ELMD Stock | USD 33.30 0.21 0.63% |
About 55% of Electromed's investor base is interested to short. The analysis of overall sentiment of trading Electromed stock suggests that many investors are impartial at this time. The current market sentiment, together with Electromed's historical and current headlines, can help investors time the market. In addition, many technical investors use Electromed stock news signals to limit their universe of possible portfolio assets.
Electromed |
Electromed, Inc. Director Andrew Summers sold 17,463 shares of the companys stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of 30.09, for a total value of 525,461.67. Following the completion of the sale, the director now owns 189,838 shares in
Read at thelincolnianonline.com
Electromed Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Electromed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Electromed Fundamental Analysis
We analyze Electromed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Electromed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Electromed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Electromed is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Electromed Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Electromed stock to make a market-neutral strategy. Peer analysis of Electromed could also be used in its relative valuation, which is a method of valuing Electromed by comparing valuation metrics with similar companies.
Peers
Electromed Related Equities
FNA | Paragon 28 | 3.00 | ||||
SGHT | Sight Sciences | 2.78 | ||||
IRMD | Iradimed | 1.72 | ||||
ITGR | Integer Holdings | 1.30 | ||||
SRDX | SurModics | 1.11 | ||||
LUNG | Pulmonx Corp | 0.66 | ||||
LIVN | LivaNova PLC | 0.35 | ||||
KIDS | Orthopediatrics Corp | 0.07 | ||||
NPCE | Neuropace | 0.14 | ||||
AORT | Artivion | 0.52 | ||||
OFIX | Orthofix Medical | 0.54 | ||||
AXGN | Axogen | 1.06 | ||||
CNMD | CONMED | 3.54 |
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |